20 Jan 2017
by
Share
tweet

Here we focused on the role of the immune system in cancer progression, and on the development of cancer immunotherapies.

Organizers Institution
Therese Sorlie Oslo University Hospital
Vanessa Dumeaux McGill Universiy
Michael Hallett McGill University
Organizing committee
Bjorn Fjukstad The Arctic University of Norway
Silje Nord Oslo University Hospital
Ali Madani Princess Margaret Hospital, U of Toronto
Einar Holsbo The Arctic University of Norway
Allen Zhang University of British Columbia
Invitees
Dana Pe’er Columbia University
Fraser Symmans MD Anderson
Quaid Morris University of Toronto
Jens Lagergren KTH
Benjamin Haibe-Kains Princess Margaret Hospital, U of Toronto
Paul Boutros OICR, U of Toronto
Johan Vallon Christersson Lund University
Jim Lorens University of Bergen
Markus Ringner SciLife Lab
Kalle Malmberg Oslo University Hospital
Daniel De Carvalho UHN, U of Toronto
Joaquim Arribas Vall D’Hebron Insitute of Oncology
Nils Halberg University of Bergen
Juri Reimand OICR, U of Toronto
Pam Ohashi UHN, U of Toronto
Jenn Listgarten Microsoft Research
Brad Nelson BC Cancer Agency
Ole Christian Lingjaerde Oslo University
Andrew McPherson University of British Columbia
Sylvie Mader IRIC, U of Montreal
Bob Clarke Georgetown University
Rejean Lapointe CRCHUM, U of Montreal
John Stagg University of Montreal
Sandra Pommey University of Montreal
E. John Werry University of Pennsylvania
Jonathan Irish Vanderbilt University
Rebecca Ihrie Vanderbilt University
Christos Hatzis Yale University
Celine Laumont IRIC, U of Montreal
Claudia Kleinman Jewish General Hospital and McGill
Etienne Gagnon IRIC, U of Montreal
Mark Basik Jewish General Hospital and McGill
Alex Rubinsteyn Mount Sinai hospital, NY